Callan Capital »

Halozyme Therapeutics shares owned by Callan Capital

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Callan Capital from 13F filings

Historical chart of Callan Capital investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Callan Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Callan Capital

Quarter filed Position value Share count Share price at filing
2013-03-31 $962k 159k 6.04
2012-12-31 $1.1M 159k 6.71

More positions owned by Callan Capital

Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Schwab Strategic Tr Schwab Fdt Us Lg (FNDX)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Schwab Strategic Tr Schwb Fdt Int Lg (FNDF)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Invesco Exchange Traded Fd T Ftse Rafi 1000 (PRF)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Schwab Strategic Tr Schwab Fdt Us Bm (FNDB)
American Centy Etf Tr Intl Smcp Vlu (AVDV)
Goldman Sachs Etf Tr Activebeta Int (GSIE)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Tr Intl Eqty Factor (INTF)
Apple (AAPL)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Select Sector Spdr Tr Technology (XLK)

View all positions for Callan Capital

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
Snyder Capital Management
Artisan Partners Limited Partnership
Alliancebernstein
Jpmorgan Chase & Co
Geode Capital Management
TD Asset Management
Jennifer Ranahan
Arrowpoint Asset Management
Northern Trust
Thrivent Financial for Lutherans
Bank of America Corporation
Dimensional Fund Advisors
Charles Schwab Investment Management

View all funds holding Halozyme Therapeutics